CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Dr. Gordon Smith, an expert on critical illness myopathy, joins researchers Dr. Shahar Shelly, who focuses on CMAP duration, and Dr. Teerin Liewluck, who studies myosin loss's impact on mortality. They delve into the vital link between CMAP duration and myosin loss, revealing surprising correlations. The discussion highlights the intricate relationship between muscle weakness, neuropathy, and the challenges in ICU care. Additionally, they emphasize personalized treatment strategies for patients facing these conditions and the importance of accurate diagnosis.